Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Recruiting4
Other2

Role Distribution

Principal Investigator5
Other Roles1
PI Rate83%

Activity Timeline

Clinical Trials (6)

NCT07485049Early Phase 1Recruiting
BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
Glioblastoma (GBM)
PrincipalinvestigatorStart date: 2026-05-07
NCT06883747Early Phase 1Recruiting
Clinical Trial of BMS-986504 in Recurrent GBM Patients
Glioblastoma WHO Grade IV
PrincipalinvestigatorStart date: 2025-04-28
NCT05940493Phase 2Recruiting
Abemaciclib in Newly Diagnosed Meningioma Patients
Meningioma
PrincipalinvestigatorStart date: 2025-03-24
NCT06388733Phase 3Active Not Recruiting
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
Brain Neoplasms, Adult, MalignantBrain TumorGBM+1 more
StudychairStart date: 2024-06-19

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT07485049Early Phase 1PrincipalInvestigator

BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors

Glioblastoma (GBM)
Recruiting
NCT07268053Early Phase 1PrincipalInvestigator

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

Brain MetastasasesGlioblastoma (GBM)
Recruiting
NCT06824662Early Phase 1PrincipalInvestigator

Phase 0 With Expansion Phase Clinical Trial of Quisinostat Plus Radiotherapy in Newly-diagnosed and Recurrent Grade 4 IDH-Wildtype Glioblastomas

Glioblastoma WHO Grade IV
Active Not Recruiting
NCT06883747Early Phase 1PrincipalInvestigator

Clinical Trial of BMS-986504 in Recurrent GBM Patients

Glioblastoma WHO Grade IV
Recruiting
NCT05940493Phase 2PrincipalInvestigator

Abemaciclib in Newly Diagnosed Meningioma Patients

Meningioma
Recruiting
NCT06388733Phase 3StudyChair

A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma

Brain Neoplasms, Adult, MalignantBrain TumorGBM+1 more
Active Not Recruiting

All 6 trials loaded